← Back to Clinical Trials
Recruiting NCT07438223

NCT07438223 Effect Of Brain Gym Exercises On Balance And Quality Of Life In Children With Spastic Diplegia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07438223
Status Recruiting
Phase
Sponsor Cairo University
Condition Cerebral Palsy (CP)
Study Type INTERVENTIONAL
Enrollment 44 participants
Start Date 2025-12-01
Primary Completion 2026-06-01

Eligibility & Interventions

Sex All sexes
Min Age 6 Years
Max Age 8 Years
Study Type INTERVENTIONAL
Interventions
Brain gym exercisesConventional physical therapy program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 44 participants in total. It began in 2025-12-01 with a primary completion date of 2026-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Statement of the problem Do brain gym exercises affect balance and quality of life in children with spastic diplegia? Null hypotheses: 1. There will be no significant effect of brain gym exercises on balance in children with spastic diplegia. 2. There will be no significant effect of brain gym exercises on quality of life in children with spastic diplegia.

Eligibility Criteria

Inclusion Criteria: 1 - Children with spastic diplegia who have balance problems in standing and gait. 2-Degree of spasticity ranges from 1 and 1+, according to modified Ashworth scale (MAS) . 3- The age of children will range from 6 to 8 years old. 4-The height of children will be at least one meter. 5- Children are levels I and II according to GMFCS (Gross Motor Classification System ). Exclusion Criteria: 1. Children with visual or auditory problems. 2. Children with intellectual disability. 3. Children have been injected with Botox injection or have done surgery in the last 6 months.

Contact & Investigator

Central Contact

Hebatallah Mohamed Kamal, Professor

✉ heba.kamal@pt.cu.edu.eg

📞 +201065263619

Principal Investigator

Hagar Mohamed Awaad, Assistant lecturer

PRINCIPAL INVESTIGATOR

Cairo University

Frequently Asked Questions

Who can join the NCT07438223 clinical trial?

This trial is open to participants of all sexes, aged 6 Years or older, up to 8 Years, studying Cerebral Palsy (CP). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07438223 currently recruiting?

Yes, NCT07438223 is actively recruiting participants. Contact the research team at heba.kamal@pt.cu.edu.eg for enrollment information.

Where is the NCT07438223 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT07438223 clinical trial?

NCT07438223 is sponsored by Cairo University. The principal investigator is Hagar Mohamed Awaad, Assistant lecturer at Cairo University. The trial plans to enroll 44 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology